The cost of delayed wound care: What payers need to know
Delayed wound care drives avoidable costs — and for payers, those costs can be substantial. Each year, U.S. health plans spend billions on wound-related treatment, complications and prolonged care episodes.
New real-world data from more than 15,000 patients shows how earlier intervention with an advanced topical therapy is tied to faster healing and lower overall treatment costs, including less reliance on costly follow-on treatments like skin substitutes.
This report highlights outcomes from a large-scale registry analysis, showing leaders how treatment timing impacts both spend and clinical success.
Inside, you'll find:
New real-world data from more than 15,000 patients shows how earlier intervention with an advanced topical therapy is tied to faster healing and lower overall treatment costs, including less reliance on costly follow-on treatments like skin substitutes.
This report highlights outcomes from a large-scale registry analysis, showing leaders how treatment timing impacts both spend and clinical success.
Inside, you'll find:
- Wound size reductions of 33–43% by week 4, with consistent results across wound types
- A 62% final healing rate overall — with patients younger than 65 seeing healing rates over 70%
- Fewer skin substitute applications vs. prior benchmarks, signaling lower downstream spend
Please fill out the form to download the whitepaper.